Amin Makarem

Stock Analyst at Jefferies

(1.91)
# 3,307
Out of 5,040 analysts
2
Total ratings
50%
Success rate
22.2%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Amin Makarem

UroGen Pharma
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $36.98
Upside: +8.17%
Foghorn Therapeutics
Feb 16, 2026
Reiterated: Buy
Price Target: $12
Current: $1.99
Upside: +503.02%